CheckMyRecalls

SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP

Published
14 Jan 2026
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.

Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493

Brand / company
SpecGx, LLC
Codes / lots
Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027. | Lot: 0522J23493, expires: 03/2027.
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.